Coping with childhood anxiety amid returning to the classroom; new global tracker measures pandemic's impact on education worldwide; Covid-19 drives innovation and evolution in patient care...
Researchers at Michigan Medicine are helping lead the first national study of how highly allergic people react to mRNA COVID-19 vaccines. The trial, co-led by a U-M immunologist, will cover over 3,000 participants receiving the Pfizer and Moderna vaccines at up to 35 academic allergy research centers across the United States.
For the first time, a team of researchers has captured X-ray images of a critical enzyme of the COVID-19 virus performing its function. This discovery could improve design of new treatments against the disease.
• Most patients with kidney failure who were undergoing hemodialysis developed a positive antibody response after being vaccinated for COVID-19, but their response was lower than that of individuals without kidney disease.
Chulalongkorn Veterinary Science (CUVET) unveils its latest effort in training a pack of sniffer dogs to detect people with COVID–19. The project first six reached 95% accuracy, and are ready for duty at airports in support of the normal screening process.
A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes. The studies that the authors examined look at several potential disease mechanisms, and also at the relationship between pollution, respiratory viruses and health disparities.
Today, the American Society of Nephrology (ASN) announced seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge. From December to January, healthcare providers, dialysis centers, nonprofit health systems, and other entrants submitted solutions that could reduce the transmission of coronavirus among people with kidney disease and/or reduce the risk of kidney damage among people who contract the virus.
Rutgers will help determine the prevalence of the coronavirus in Newark, one of the cities hardest hit by the pandemic, as part of the National Institutes of Health COVID-19 Prevention Network (CoVPN) response to the deadly global outbreak.
NIH has awarded four additional contracts for the development and scaled-up manufacturing of new COVID-19 diagnostic testing technologies through its Rapid Acceleration of Diagnostics Tech (RADx) initiative. The awards total $29.3 million and will help increase testing capacity for COVID-19.
“Near-poor” Americans – people just above the federal poverty level but still well below the average U.S. income – who rely on Medicare for health insurance face high medical bills and may forgo essential health care, according to new research.
A new study examines the recent literature on carbon nanotubes toxicity highlighting their strong inflammatory potential for the respiratory system.
Emergency medical service (EMS) workers face triple the risk for significant mental health problems such as depression and posttraumatic stress disorder compared to the general population, according to a recently published study by researchers from Syracuse University.
Public trust in the federal Centers for Disease Control and Prevention has fallen during the coronavirus pandemic, with the decline bringing overall population-level trust in the agency to the same lower level of trust long held by Black Americans about the agency, according to a new RAND Corporation study.
Program, an official partner of the New York State Excelsior Pass program, offers fast and accurate testing
Atlantic Health System is among the first hospitals in the region to be able to rapidly screen for key viral variants, a key advance for public health amid the pandemic.
SEATTLE — April 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. April is National Minority Health Month, with a focus on the disproportionate impacts of COVID-19 on communities of color. See more details below on related Fred Hutch programming.Save the date for our monthly public science event, “Science Says” on Tuesday, April 27.
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of MedUni Vienna and Vienna General Hospital performed a lung transplant on a 44-year-old patient who had been seriously ill with Covid-19, making her the first patient in Europe to receive a lung transplant for this indication.
A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai study published today by the journal Nature Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right